Below are the most recent publications written about "Administration, Intravenous" by people in Profiles.
-
Maguire AS, Ta NL, Gross AL, Garrett CJ, Zimmerman AD, Diffie EB, Osterhoudt DE, Pacer SH, Mitchell ML, Cannon JS, Hall PI, Sandey M, Cole RC, Seyfried TN, Gray-Edwards HL, Sena-Esteves M, Martin DR. Intravenous gene therapy improves life span and clinical outcomes in a feline model of Sandhoff disease. Sci Transl Med. 2026 09 09; 18(866):eadx2447.
-
Xiang Y, Yang S, Guo L, Dong C, Majoie CBLM, Siddiqui AH, Mocco J, Cavalcante F, Li BH, Wang JH, Huang B, Wang DZ, Yu NW, Schonewille WJ, Turk AS, Guo FQ. BEST-BAO: a multicentre, prospective, randomised controlled trial of endovascular treatment with or without intravenous thrombolysis in acute ischaemic stroke due to basilar artery occlusion - study protocol and rationale. Stroke Vasc Neurol. 2026 Jun 29; 11(3):358-364.
-
Wan F, He J, Ma H, PiresFerreira D, Kumanan V, Lee JS, Chen X, He R, Su Q, Gallagher TL, Zhu S, Cabrera GT, Zhao L, Shen J, Gruntman A, Brown RH, Xu Z, Gao G, Xie J. Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model. Nat Commun. 2026 06 25; 17(1).
-
Segall RE, Lamontagne F, Vail EA, Wunsch H, Bosch NA, Walkey AJ, Pinto R, Gershengorn HB, Adhikari NKJ. Trends in Use of IV Vitamin C Among Patients With Sepsis. Crit Care Med. 2026 Mar 01; 54(3):607-612.
-
Yaghi S, Shu L, Mistry EA, Adeoye O, Schwamm L, Messe S, Elkind MSV, Ghannam M, de Havenon A, Furie K, Xian Y, Streib C, Wangqin R, Henninger N, Saver JL, Smith EE. Intravenous Thrombolysis in Patients on Direct Oral Anticoagulants: Analysis of the Get With The Guidelines Stroke Registry. J Am Heart Assoc. 2026 01 06; 15(1):e044321.
-
Galbiati F, Plessow F, Plummer L, Campbell MB, Nazarloo S, Carter CS, Davis JM, Miller KK, Carroll RS, Kaiser UB, Seminara SB, Aulinas A, Lawson EA. Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans. J Neuroendocrinol. 2026 Jan; 38(1):e70114.
-
Meinel TR, Bücke P, D'Anna L, Merlino G, Aguiar de Sousa D, Poli S, Purrucker JC, Strambo D, Romoli M, De Marchis GM, Pfeilschifter W, Zedde M, Marto JP, Candelaresi P, Lemmens R, Scoppettuolo P, Woock M, Kermer P, Kristoffersen ES, Ghannam M, Frol S, Nolte CH, Yakushiji Y, Touzé E, Uphaus T, Mannino M, Ntaios G, Padjen V, Henninger N, Zipser-Mohammadzada F, Mariano ME, Guerreiro C, Burini A, Ceccarelli L, Valente M, Gomez-Exposito A, Kleeberg A, Thevoz G, Michel P, Stufano G, Vlachos D, Herrmann M, Rodrigues B, Spina E, Andreone V, Allardt A, Alshaer QN, Riegler C, Kunieda T, Boulanger M, Hahn M, Papadimitriou D, Muppa J, Maes L, Ranta A, Tyson A, Barber PA, Davis AJ, Wu TY, Kaesmacher J, Fischer U, Seiffge DJ. Intravenous Thrombolysis in Patients With Recent Intake of Direct Oral Anticoagulants: A Target Trial Analysis and Comparison With Reversal Agent Use. Stroke. 2025 Oct; 56(10):2836-2845.
-
Galbiati F, Plessow F, Plummer L, Campbell MB, Nazarloo S, Carter CS, Carroll RS, Kim HK, Pereira SA, Paulis D, Davis JM, Miller KK, Kaiser UB, Seminara SB, Aulinas A, Lawson EA. Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humans. Eur J Endocrinol. 2025 Mar 03; 192(3):K24-K29.
-
Shu L, Lee E, Field TS, Guo X, Henninger N, Keser Z, Khan M, Mistry EA, Nguyen TN, Siegler JE, Strelecky L, Mandel DM, Stretz C, Furie KL, Yaghi S. Intravenous Thrombolysis in Cervical Artery Dissection-Related Stroke: A Nationwide Study. J Am Heart Assoc. 2025 03 04; 14(5):e039662.
-
Ganesan V, Steinberg RL, Trivedi H, Sorokin I, Johnson BA, Gahan JC. Scheduled intravenous ketorolac is safe and reduces narcotic use after robotic-assisted simple prostatectomy. J Robot Surg. 2024 Oct 03; 18(1):358.